Related papers: ZeroDDI: A Zero-Shot Drug-Drug Interaction Event P…
Deep learning models achieve high accuracy in segmentation tasks among others, yet domain shift often degrades the models' performance, which can be critical in real-world scenarios where no target images are available. This paper proposes…
Characterizing interactions between drugs is important to avoid potentially harmful combinations, to reduce off-target effects of treatments and to fight antibiotic resistant pathogens, among others. Here we present a network inference…
In this research, we present our work participation for the DrugProt task of BioCreative VII challenge. Drug-target interactions (DTIs) are critical for drug discovery and repurposing, which are often manually extracted from the…
Drug repositioning (DR) refers to identification of novel indications for the approved drugs. The requirement of huge investment of time as well as money and risk of failure in clinical trials have led to surge in interest in drug…
Multimodal learning typically utilizes multimodal joint loss to integrate different modalities and enhance model performance. However, this joint learning strategy can induce modality imbalance, where strong modalities overwhelm weaker ones…
Dense retrieval (DR) methods conduct text retrieval by first encoding texts in the embedding space and then matching them by nearest neighbor search. This requires strong locality properties from the representation space, i.e, the close…
Structure-Based Drug Design (SBDD) has revolutionized drug discovery by enabling the rational design of molecules for specific protein targets. Despite significant advancements in improving docking scores, advanced 3D-SBDD generative models…
In this work, we propose a simple yet effective method to tackle the problem of imbalanced multi-class semantic segmentation in deep learning systems. One of the key properties for a good training set is the balancing among the classes.…
This paper introduces Unified Language-driven Zero-shot Domain Adaptation (ULDA), a novel task setting that enables a single model to adapt to diverse target domains without explicit domain-ID knowledge. We identify the constraints in the…
Zero-Shot Learning (ZSL) aims to classify a test instance from an unseen category based on the training instances from seen categories, in which the gap between seen categories and unseen categories is generally bridged via visual-semantic…
Simultaneous administration of multiple drugs can have synergistic or antagonistic effects as one drug can affect activities of other drugs. Synergistic effects lead to improved therapeutic outcomes, whereas, antagonistic effects can be…
Transductive Zero-shot learning (ZSL) targets to recognize the unseen categories by aligning the visual and semantic information in a joint embedding space. There exist four kinds of domain biases in Transductive ZSL, i.e., visual bias and…
Given the semantic descriptions of classes, Zero-Shot Learning (ZSL) aims to recognize unseen classes without labeled training data by exploiting semantic information, which contains knowledge between seen and unseen classes. Existing ZSL…
The identification of novel drug-target (DT) interactions is a substantial part of the drug discovery process. Most of the computational methods that have been proposed to predict DT interactions have focused on binary classification, where…
Zero-Shot Learning (ZSL) is typically achieved by resorting to a class semantic embedding space to transfer the knowledge from the seen classes to unseen ones. Capturing the common semantic characteristics between the visual modality and…
Traditional biomedical version of embeddings obtained from pre-trained language models have recently shown state-of-the-art results for relation extraction (RE) tasks in the medical domain. In this paper, we explore how to incorporate…
The Zero-Shot Learning (ZSL) task pertains to the identification of entities or relations in texts that were not seen during training. ZSL has emerged as a critical research area due to the scarcity of labeled data in specific domains, and…
Identification of drug-target interactions is an indispensable part of drug discovery. While conventional shallow machine learning and recent deep learning methods based on chemogenomic properties of drugs and target proteins have pushed…
We propose an end-to-end model to predict drug-drug interactions (DDIs) by employing graph-augmented convolutional networks. And this is implemented by combining graph CNN with an attentive pooling network to extract structural relations…
Zero-Shot Classification (ZSC) equips the learned model with the ability to recognize the visual instances from the novel classes via constructing the interactions between the visual and the semantic modalities. In contrast to the…